REGENXBIO, Inc. (RGNX)
7.225
-0.10
(-1.30%)
USD |
NASDAQ |
Nov 17, 16:00
7.225
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Price : 7.225 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 7.59 | 7.815 | 7.30 | 7.32 | 908122.0 |
| Nov 13, 2026 | 8.02 | 8.04 | 7.39 | 7.64 | 716128.0 |
| Nov 12, 2026 | 8.23 | 8.33 | 7.94 | 8.03 | 1.286M |
| Nov 11, 2026 | 7.80 | 8.88 | 7.62 | 8.47 | 1.845M |
| Nov 10, 2026 | 8.00 | 8.14 | 7.28 | 7.69 | 1.084M |
| Nov 09, 2026 | 7.77 | 8.23 | 7.47 | 8.07 | 2.174M |
| Nov 06, 2026 | 7.33 | 7.87 | 7.33 | 7.62 | 1.186M |
| Nov 05, 2026 | 7.20 | 7.68 | 7.15 | 7.38 | 1.677M |
| Nov 04, 2026 | 7.72 | 7.96 | 7.475 | 7.71 | 1.310M |
| Nov 03, 2026 | 7.29 | 7.645 | 7.266 | 7.63 | 854955.0 |
| Nov 02, 2026 | 7.27 | 7.459 | 7.04 | 7.16 | 1.029M |
| Oct 30, 2026 | 7.38 | 7.535 | 7.00 | 7.20 | 1.062M |
| Oct 29, 2026 | 7.36 | 7.63 | 7.21 | 7.41 | 1.036M |
| Oct 28, 2026 | 6.52 | 7.285 | 6.505 | 7.24 | 2.000M |
| Oct 27, 2026 | 6.54 | 6.78 | 6.459 | 6.60 | 1.225M |
| Oct 26, 2026 | 6.74 | 6.89 | 6.48 | 6.58 | 1.138M |
| Oct 23, 2026 | 7.03 | 7.08 | 6.628 | 6.68 | 1.452M |
| Oct 22, 2026 | 7.11 | 7.305 | 6.98 | 7.17 | 1.133M |
| Oct 21, 2026 | 7.42 | 7.47 | 7.15 | 7.17 | 945330.0 |
| Oct 20, 2026 | 7.15 | 7.58 | 7.06 | 7.40 | 1.316M |
| Oct 19, 2026 | 6.98 | 7.265 | 6.95 | 7.15 | 1.298M |
| Oct 16, 2026 | 7.14 | 7.18 | 6.875 | 6.925 | 1.210M |
| Oct 15, 2026 | 6.88 | 7.28 | 6.83 | 7.16 | 1.229M |
| Oct 14, 2026 | 7.12 | 7.24 | 6.80 | 6.88 | 1.567M |
| Oct 13, 2026 | 7.66 | 7.72 | 7.11 | 7.26 | 1.379M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 292.80 |
| Anika Therapeutics, Inc. | 12.89 |
| United Therapeutics Corp. | 584.21 |
| Biomea Fusion, Inc. | 0.4785 |
| ACADIA Pharmaceuticals, Inc. | 18.30 |
Price Related Metrics
| PS Ratio | 2.611 |
| Price to Book Value | 3.227 |
| Earnings Yield | -44.44% |
| Market Cap | 477.71M |